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journal homepage: www.aidm-onl ine.comEDITORIALTransnasal endoscopic gastrostomy for patients
whose condition limits standard oral
endoscopic intubationEndoscopic screening, accurate diagnosis, and minimally
invasive treatment for upper gastrointestinal neoplasms are
key challenges for gastroenterologists. In some cases,
however, traditional endoscopy may be difficult in transoral
intubation, especially when patients suffer from head and
neck cancer and their oral insertion route may be limited by
tumor obstruction, trismus related to radiotherapy, or
submucosal fibrosis due to long-term betel nut chewing.
The use of an ultrathin endoscope that can be intubated via
the nostrils appears to be an effective approach to over-
come such obstacles.
Combined with an enhanced imaging technique, trans-
nasal endoscopy has been shown to be effective in
screening synchronous or metachronous esophageal neo-
plasms and other benign lesions in patients with head and
neck cancers [1,2]. Previous studies have compared the
transoral and transnasal approaches and showed that, using
ultrathin endoscopies, both approaches have an approxi-
mately equal success rate and good patient satisfaction
[3e5].
Tube feeding is an important resource for facilitating
nutritional recovery and is increasingly used because of
global population aging. Percutaneous endoscopic gastro-
stomy (PEG) that is minimally invasive is a good method to
provide a permanent route for enteric nutrition. Compared
with traditional nasogastric tubes, PEG has the advantage
of providing a larger port and preventing the discomfort
and complications related to the use of nasogastric tubes
[6,7]. In patients whose condition limits oral intubation
with a standard endoscope, an endoscopic approach via the
nasal route is reasonable, provided that the endoscope is
thin, the PEG tube is small in caliber, and the patient’s
nostrils are sufficiently large.
In previous studies, transnasal PEG was used in patients
with head and neck cancers, dysphagia, neurologic dis-
eases, or facial fracture. Using either the pull method or
the introducer method, the success rate approached 100%,http://dx.doi.org/10.1016/j.aidm.2016.03.003
2351-9797/Copyright ª 2016, The Gastroenterological Society of Taiwan
for the Study of the Liver. Published by Elsevier Taiwan LLC. This is
creativecommons.org/licenses/by-nc-nd/4.0/).and the complication rate was low (Table 1) [8e17]. In
Taiwan, Dr Lin first reported a case-series study using
transnasal pull-type PEG. In that study, only one case failed
transnasal PEG, and the completion rate was 96.8%. Only
10% of the participants developed minor epistaxis, and
wound infections occurred in 26.6%. During PEG, contami-
nation from bacteria harbored in the upper aerodigestive
tract is inevitable, so the most common complication
associated with PEG tubes is infection via the gastrostomy
wound [18e21]. Pull-type transoral PEG has a higher
infection rate that may be as high as 36% [6,18,20]. The
physician’s endoscopic experience and the patient’s un-
derlying diseases are risk factors for transoral PEG-related
infection [22]. Theoretically, the introducer method that
allows the tube to be introduced directly via abdominal
wall puncture into the stomach may more easily avoid
bacterial contamination compared with an approach via the
aerodigestive tract [9,15,16,20]. However, the introducer
method is associated with a higher rate of bleeding and
perforation [18,21].
In the present issue of Advances in Digestive Medicine,
Dr Lin compares transnasal PEG and that using the tradi-
tional transoral approach. Highly successful rates were
achieved in both groups, but, as expected, a higher fre-
quency of epistaxis was observed in the transnasal group.
The study also addresses the infection rate associated with
both approaches and shows that infection occurred in 26.3%
and 36.8%, respectively, of patients in the transnasal and
transoral groups, and more Pseudomonas infections were
seen in the transnasal group. However, without a random-
ized allocation of patients, this study provides a descriptive
rather than a direct comparison between these two ap-
proaches, and there remains a lack of robust evidence for
the best clinical options to decrease the infection rate of
the transnasal procedure. In a previous study that included
oral and nasal swabs prior to the insertion of the PEG
tube, a higher colonization rate was observed in the, The Digestive Endoscopy Society of Taiwan and Taiwan Association
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Table 1 Summary of published studies of transnasal percutaneous endoscopic gastrostomy.
Author, year
[reference]
Method/study design/case numbers Success rate Complications Prophylactic antibiotics/
infection
Counihan
et al. 1996 [8]
Transnasal with pull method
(ultrathin scopes)
Case report: one traumatic case
with intermaxillary fixation (n Z 1)
100% No  Prophylactic
antibiotics used
 No procedure-related
infection
Lustberg
et al. 2001 [12]
Transnasal with push method
(ultrathin or pediatric scopes)
Case series: one cardiac-arrest
case and one head and neck
cancer patient (n Z 2)
100% No  Prophylactic
antibiotics used
 No procedure-related
infection
Vitale
et al. 2005 [17]
Transnasal with pull
method (ultrathin scopes)
Case series: patients with
neurologic disease, head and
neck cancer, and facial
fracture (n Z 12)
100% No  Prophylactic
antibiotics used
 No procedure-related
infection
Ogata
et al. 2007 [16]
Transnasal with introducer
method (ultrathin scopes)
Case series: patients with
neurologic disease
and head and neck
cancer (n Z 75)
100% No  Prophylactic
antibiotics used
 No procedure-related
infection
Seth
et al. 2010 [14]
Transnasal with pull
method (ultrathin scopes)
Case report: one cause with
head and neck cancer (n Z 1)
100% No  Prophylactic
antibiotics used
 No procedure-related
infection
Suzuki
et al. 2011 [15]
Transnasal vs. transoral with
introducer method (ultrathin
scopes vs. traditional scope)
Randomized controlled trial:
patients with neurologic
disease or head and neck
cancer (n Z 13 vs. 12)
100% Yes
 Infection
 Comparable
hemodynamic
change between
both groups
 Prophylactic
antibiotics used
 Procedure-related
infection: one case
of pneumonia in
transnasal group
Lin et al. 2013 [11] Transnasal with pull method
(ultrathin scopes)
Case series: patients with
dysphagia (n Z 31)
96.8% Yes
 Epistaxis: 10%
 Infection: 33%
 Prophylactic
antibiotics used
 Procedure-related
infection: Pseudomonas
wound infection:
8 (26.6%); urinary-tract
infection: 2 (6.7%)
Lee et al. 2014 [9] Transnasal with introducer
method (ultrathin scopes)
Case series: patients with
neurologic disease or head or
neck cancer (n Z 75)
97.8% No  Prophylactic
antibiotics used
 No procedure-related
infection
Nevah
et al. 2014 [13]
Transnasal with push method
(ultrathin scopes)
Case series: patients with head
and neck cancer (n Z 16)
100% Yes
 Poor healing: 6%
 Infection: 6%
 Prophylactic
antibiotics used
 Procedure-related
infection: wound
infection: 1 (6%)
Lin 2016 [10] Transnasal vs. transoral with pull
method (ultrathin scopes vs.
traditional scope)
Retrospective case-control:
patients with dysphagia
(n Z 38 vs. 38)
97% vs. 100% Yes
 Epistaxis 5% vs. 0%
 Choking: 8% vs. 13%
 Infection: 33%
 Prophylactic antibiotics
used
 Procedure-related
infection: wound
infection 10 (26.3%) vs.
14 (36.8%); Pseudomonas
wound infection:
9 (90%) vs. 8 (57%)
Editorial 41
42 Editorialoropharyngeal group than nasal colonization (68% vs. 19%)
[18]. The authors suggested that differences in the PEG
infection rate might be attributable to differences in bac-
terial colonization between the nasal and oral cavities.
Further studies are therefore necessary to evaluate the use
of prophylactic antibiotics or nasal/oral cavity disinfection
on the decrease of the infection risk related to this pro-
cedure. Then the prognosis and outcome for these patients
may be improved.
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